Want to join the conversation?
$R raises 4Q15 earnings forecast range of $1.72-1.82 per share, up 8-14% from the same period last year. Fourth quarter earnings will be benefited by a reduction of $0.02, due to the absence of anti-dilutive share repurchases. $R forecast full-year 2015 comparable EPS of $6.17-6.29, up 11% from full-year 2014.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?